At issue is mifepristone, part of a two-drug protocol used in medication abortions, the most common form of the procedure today. Under current Food and Drug Administration protocols, the drug can be prescribed during a remote doctor visit and obtained both from mail-order pharmacies and local drugstores such as CVS and Walgreens.
Russian Court Extends WSJ Reporter Evan Gershkovich's Detention
A Russian court extended the detention of Evan Gershkovich by three months, almost a year to the day since The Wall Street Journal reporter became the first U.S. journalist to be detained there on an allegation of espionage since the end of the Cold War.
The 32-year-old reporter, whom the U.S. government deems wrongfully detained, has been held in Moscow's Lefortovo Prison since March 29 last year, on an allegation that he, the Journal and the U.S. government vehemently deny.
Write to paul.larkins@dowjones.com TODAY IN CANADA
Earnings [4Q unless stated otherwise]:
Allied Gold
Aptose Biosciences
Bragg Gaming
G Mining Ventures
Galaxy Digital
Greenlane Renewables
Orezone Gold
Sagicor Financial
Tantalus Sysyems
Economic Calendar:
Nothing scheduled
Stocks to Watch:
Karnalyte Resources 2023 Loss/Shr C$0.03
Mountain Province 4Q, Full-Year 2023 Results to Be Released After-Market on April 1; Delay Due to Financial Audit Process Not Being Completed by Planned Date
Expected Major Events for Tuesday
06:00/JPN: Feb Revised Machine Tool Orders
07:00/GER: Apr GfK consumer climate survey
12:30/US: Feb Advance Report on Durable Goods
12:55/US: 03/23 Johnson Redbook Retail Sales Index
13:00/US: Jan U.S. Monthly House Price Index
13:00/US: Jan S&P CoreLogic Case-Shiller Indices
14:00/US: Mar Richmond Fed Business Activity Survey
14:00/US: Mar Consumer Confidence Index
17:00/US: Feb Money Stock Measures
20:30/US: API Weekly Statistical Bulletin
All times in GMT. Powered by Kantar Media and Dow Jones.
Expected Earnings for Tuesday
Adicet Bio Inc (ACET) is expected to report $-0.71 for 4Q.
Aimia (AIM.T) is expected to report for 4Q.
CXApp Inc (CXAI,CXAIV) is expected to report $-0.35 for 4Q.
CorEnergy Infrastructure Trust Inc (CORR) is expected to report for 4Q.
Dakota Gold Corp (DC) is expected to report for 4Q.
Delcath Systems Inc (DCTH) is expected to report $-0.54 for 4Q.
Enviva Inc (EVA) is expected to report $-0.49 for 4Q.
Forge Global Holdings Inc (FRGE) is expected to report $-0.11 for 4Q.
Gelesis Holdings Inc (GLSHQ) is expected to report for 4Q.
Helix BioPharma (HBP.T,HBPCF) is expected to report for 2Q.
ImmunityBio Inc (IBRX) is expected to report $-0.33 for 4Q.
InVivo Therapeutics Holdings Corp (NVIVQ) is expected to report for 4Q.
Intrusion Inc (INTZ) is expected to report for 4Q.
Iridex (IRIX) is expected to report $-0.24 for 4Q.
Kinnate Biopharma Inc (KNTE) is expected to report $-0.47 for 4Q.
LiveWorld Inc (LVWD) is expected to report for 4Q.
Luna Innovations (LUNA) is expected to report $0.09 for 4Q.
Mannatech Inc (MTEX) is expected to report for 4Q.
McCormick & Co (MKC) is expected to report $0.58 for 1Q.
Momentus Inc (MNTS) is expected to report for 4Q.
Movado Group Inc (MOV) is expected to report $0.39 for 4Q.
NanoString Technologies Inc (NSTGQ) is expected to report $-0.51 for 4Q.
Ocugen Inc (OCGN) is expected to report $-0.06 for 4Q.
Orchestra BioMed Holdings Inc (OBIO) is expected to report for 4Q.
Orgenesis Inc (ORGS) is expected to report for 4Q.
P & F Industries Inc (PFIN) is expected to report for 4Q.
Patriot National Bancorp Inc (PNBK) is expected to report for 4Q.
Perspective Therapeutics Inc (CATX) is expected to report $-0.02 for 4Q.
ProMIS Neurosciences Inc (PMN) is expected to report $-0.17 for 4Q.
Quince Therapeutics Inc (QNCX) is expected to report for 4Q.
Seritage Growth Properties (SRG) is expected to report for 4Q.
Singing Machine Co Inc (MICS) is expected to report for 3Q.
TAG Oil (TAO.V,TAOIF) is expected to report for 3Q.
TD SYNNEX Corp (SNX) is expected to report $2.30 for 1Q.
Unity Biotechnology Inc (UBX) is expected to report $-0.39 for 4Q.
Valeura Energy (PNWRF,VLE.T) is expected to report for 4Q.
Velo3D Inc (VLD) is expected to report for 4Q.
Vigil Neuroscience Inc (VIGL) is expected to report $-0.52 for 4Q.
Yield10 Bioscience Inc (YTEN) is expected to report $-0.31 for 4Q.
Zura Bio Ltd (ZURA) is expected to report $-0.23 for 4Q.
Powered by Kantar Media and Dow Jones.
ANALYST RATINGS ACTIONS
Aehr Test Systems Cut to Market Perform From Outperform by William Blair
Avis Budget Group Raised to Buy From Neutral by Northcoast Research
BigCommerce Holdings Cut to Underperform From Neutral by B of A Securities
BWX Technologies Cut to Hold From Buy by Truist Securities
Centene Cut to Equal-Weight From Overweight by Stephens & Co.
Cincinnati Fincl Raised to Outperform From Market Perform by BMO Capital
Curtiss-Wright Cut to Hold From Buy by Truist Securities
Dave & Buster's Cut to Market Perform From Outperform by Raymond James
Disney Raised to Overweight From Equal-Weight by Barclays
Financial Institutions Cut to Neutral From Overweight by Piper Sandler
Foot Locker Raised to Outperform From In-Line by Evercore ISI Group
Golub Capital BDC Raised to Buy From Neutral by B of A Securities
GoodRx Holdings Raised to Overweight From Equal-Weight by Wells Fargo
Kinder Morgan Cut to Hold From Buy by Truist Securities
Laboratory Corp. Raised to Buy From Hold by Argus Research
Masimo Raised to Overweight From Equal-Weight by Wells Fargo
McDonald's Cut to Hold From Buy by Argus Research
Rivian Automotive Cut to Neutral From Buy by Mizuho
Scotts Miracle-Gro Cut to Market Perform From Strong Buy by Raymond James
Sotera Health Raised to Buy From Hold by Jefferies
Tempur Sealy Raised to Buy From Hold by Loop Capital
Tesla Cut to Neutral From Buy by Mizuho
This article is a text version of a Wall Street Journal newsletter published earlier today.
(END) Dow Jones Newswires
03-26-24 0607ET
